Evidence map›Paper›PMID 42357263›Full record

ArticlePharmaceutics2026

Optimized TELIP, an Echogenic Liposomal Nano-Carrier Loaded with Alteplase for Preclinical Studies.

Maryam Ranjpour, Brion Frierson, Rebekah Lynn Emerine, Christian Jordan De Vera, Krishna Sarva, Melvin Earl Klegerman, David Dugald McPherson, Steven Idell, Galina Florova, Andrey Anatolievich Komissarov

Abstract read
In one paragraph

Article in Pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Maryam RanjpourDepartment of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, TX 75708, USA.
Brion FriersonDepartment of Internal Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
Rebekah Lynn EmerineDepartment of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, TX 75708, USA.
Christian Jordan De VeraDepartment of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, TX 75708, USA.
Krishna SarvaDepartment of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, TX 75708, USA.
Melvin Earl KlegermanDepartment of Internal Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.ORCID 0000-0001-7458-0659
David Dugald McPhersonDepartment of Internal Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
Steven IdellDepartment of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, TX 75708, USA.
Galina FlorovaDepartment of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, TX 75708, USA.
Andrey Anatolievich KomissarovDepartment of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, TX 75708, USA.

Funding

National Heart Lung and Blood Institute 1R01HL152059-01
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

alteplasecarrierdeliveryechogenicencapsulationfibrinolysisliposomesctPAtargetedTELIP

Identifiers

PMID42357263
PMCPMC13304843

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.